A study led by researchers at the Icahn School of Medicine at Mount Sinai has identified a potential drug that is able to drive human insulin-producing beta cells to multiply. This may prove to be a potential treatment for diabetes, a disease characterized by a lack of beta cells in the pancreas to produce insulin, the hormone needed to regulate blood glucose levels. The findings are published in the online journal

People suffering from diabetes do not have enough insulin in their body essential for regulating their blood sugar levels. A primary cause of this is that diabetics do not have enough pancreatic beta cells to produce enough insulin in their body. This lack of insulin making cells may someday be addressed as researchers have discovered a mechanism in the body that may convert other cell types into pancreatic beta ce

Researchers are now trying to find a way of treating diabetes using stem cells. According to a new study, it may just be a step or two away. Researchers from Novocell Inc., a stem cell engineering company in San Diego reports that they may have found a way to convert human embryonic stem cells into insulin producing cells. According to Dr. Emmanuel Baetge, chief scientific officer at Novocell Inc. and the primary